Failure of 17-hydroxyprogesterone to reduce neonatal morbidity or prolong triplet pregnancy: a double-blind, randomized clinical trial.

Combs, C Andrew

Failure of 17-hydroxyprogesterone to reduce neonatal morbidity or prolong triplet pregnancy: a double-blind, randomized clinical trial. [electronic resource] - American journal of obstetrics and gynecology Sep 2010 - 248.e1-9 p. digital

Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

1097-6868

10.1016/j.ajog.2010.06.016 doi


17-alpha-Hydroxyprogesterone--therapeutic use
Abortion, Spontaneous--epidemiology
Adult
Double-Blind Method
Female
Fetal Death--epidemiology
Gestational Age
Humans
Infant, Newborn
Infant, Newborn, Diseases--epidemiology
Pregnancy
Pregnancy Complications--epidemiology
Pregnancy, High-Risk
Pregnancy, Multiple
Premature Birth--prevention & control
Triplets